Brief: INVO Fertility To Restate Unaudited Financials For Q1, Q2, And Q3 2025 - SEC Filing
02/06/2026 13:37
BRIEF-INVO Fertility To Restate Unaudited Financials For Q1, Q2, And Q3 2025 - SEC Filing June 2 (Reuters) - INVO Fertility Inc IVF.O:
INVO FERTILITY - TO RESTATE UNAUDITED FINANCIALS FOR Q1, Q2, AND Q3 2025 - SEC FILING
INVO FERTILITY - AUDIT COMMITTEE SAYS Q1, Q2, Q3 2025 FINANCIALS SHOULD NOT BE RELIED UPON - SEC FILING
INVO FERTILITY - ERRORS DO NOT IMPACT REVENUE OR LOSS FROM OPERATIONS - SEC FILING
Source text: [ID:n0001493152-26-026772]
Further company coverage: IVF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on INVO Fertility
See all newsINVO Fertility Q2 revenue rises, partly on acquisitions
Invo Fertility Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Invo Fertility Inc Expected To Post A Loss Of 70 Cents A Share: Earnings Preview
Brief: INVO Fertility - Entered Into Any Market Purchase Agreement With Alumni Capital Lp
Invo Fertility Inc Reports Results For The Quarter Ended March 31: Earnings Summary